These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 27037063)

  • 1. Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
    Koziolek M; Grimm M; Schneider F; Jedamzik P; Sager M; Kühn JP; Siegmund W; Weitschies W
    Adv Drug Deliv Rev; 2016 Jun; 101():75-88. PubMed ID: 27037063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based In vitro Models to Predict the Oral Dissolution and Absorption of a Solid Drug Delivery System.
    Li Z; He X
    Curr Drug Metab; 2015; 16(9):777-806. PubMed ID: 26264200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH.
    Abuhelwa AY; Foster DJR; Upton RN
    AAPS J; 2016 Sep; 18(5):1309-1321. PubMed ID: 27495120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulating the postprandial stomach: biorelevant test methods for the estimation of intragastric drug dissolution.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 Jun; 10(6):2211-21. PubMed ID: 23654347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative Analysis of Gastrointestinal Physiology for Better Prediction of Oral Drug Absorption and Interaction].
    Shirasaka Y
    Yakugaku Zasshi; 2020; 140(5):599-608. PubMed ID: 32378658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesion and the gastrointestinal tract.
    Varum FJ; McConnell EL; Sousa JJ; Veiga F; Basit AW
    Crit Rev Ther Drug Carrier Syst; 2008; 25(3):207-58. PubMed ID: 18540839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AC biosusceptometry in the study of drug delivery.
    Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms.
    Otsuka K; Shono Y; Dressman J
    J Pharm Pharmacol; 2013 Jul; 65(7):937-52. PubMed ID: 23738721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patches for improving gastrointestinal absorption: an overview.
    Teutonico D; Ponchel G
    Drug Discov Today; 2011 Nov; 16(21-22):991-7. PubMed ID: 21683153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biorelevant in-vitro performance testing of orally administered dosage forms.
    Reppas C; Vertzoni M
    J Pharm Pharmacol; 2012 Jul; 64(7):919-30. PubMed ID: 22686340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug dissolution: significance of physicochemical properties and physiological conditions.
    Jambhekar SS; Breen PJ
    Drug Discov Today; 2013 Dec; 18(23-24):1173-84. PubMed ID: 24042023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.
    Lennernäs H; Lindahl A; Van Peer A; Ollier C; Flanagan T; Lionberger R; Nordmark A; Yamashita S; Yu L; Amidon GL; Fischer V; Sjögren E; Zane P; McAllister M; Abrahamsson B
    Mol Pharm; 2017 Apr; 14(4):1307-1314. PubMed ID: 28195732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamic gastric environment and its impact on drug and formulation behaviour.
    Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical applications of AC biosusceptometry.
    Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
    Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Oral Absorption Modelling to Study Gut-Level Drug Interactions.
    Chung J; Kesisoglou F
    J Pharm Sci; 2018 Jan; 107(1):18-23. PubMed ID: 28847476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location, location, location: gastrointestinal delivery site and its impact on absorption.
    Connor A
    Ther Deliv; 2012 May; 3(5):575-8. PubMed ID: 22834401
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving oral delivery.
    Gabor F; Fillafer C; Neutsch L; Ratzinger G; Wirth M
    Handb Exp Pharmacol; 2010; (197):345-98. PubMed ID: 20217536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.